Korean J Intern Med > Volume 36(1); 2021 > Article |
|
Characteristic | Total (n = 565) | Control (n = 161) | Corticosteroid-treated (n = 404) | p value |
---|---|---|---|---|
Age, yr | 63 ± 13 | 63 ± 15 | 63 ± 13 | 0.932 |
Male sex | 379 (67.1) | 122 (75.8) | 257 (63.6) | 0.006 |
SOFA score | 11 ± 4 | 11 ± 4 | 11 ± 4 | 0.416 |
Body mass index, kg/m2 | 22.6 ± 4.0 | 22.8 ± 4.6 | 22.5 ± 3.7 | 0.559 |
Glasgow coma score | 3 (2–9) | 4 (2–9) | 2 (2–9) | 0.416 |
PaO2/FiO2 ratio | 100 (71–136) | 105 (77–141) | 97 (67–133) | 0.065 |
Comorbidity | ||||
Diabetes mellitus | 182 (32.2) | 60 (37.3) | 122 (30.2) | 0.105 |
Solid tumor | 169 (29.9) | 58 (36.0) | 111 (27.5) | 0.045 |
Cardiovascular disease | 38 (6.7) | 12 (7.5) | 26 (6.4) | 0.663 |
Chronic pulmonary disease | 77 (13.6) | 19 (11.8) | 58 (14.4) | 0.424 |
Chronic kidney disease | 45 (8.0) | 12 (7.5) | 33 (8.2) | 0.777 |
Cerebrovascular disease | 43 (7.6) | 17 (10.6) | 26 (6.4) | 0.095 |
Hematologic disease | 73 (12.9) | 11 (6.8) | 62 (15.4) | 0.007 |
Chronic liver disease | 73 (12.9) | 30 (18.6) | 43 (10.6) | 0.011 |
Post-transplant | 49 (8.7) | 4 (2.5) | 45 (11) | 0.001 |
Cause of ARDS | ||||
CAP | 100 (17.7) | 26 (16.2) | 74 (18.3) | 0.542 |
HCAP | 147 (26.0) | 28 (17.4) | 119 (29.5) | 0.003 |
HAP | 100 (17.7) | 32 (19.9) | 68 (16.8) | 0.392 |
Aspiration | 56 (9.9) | 23 (14.3) | 33 (8.2) | 0.028 |
Othera | 35 (6.2) | 5 (3.1) | 30 (7.4) | 0.055 |
Sepsis | 89 (15.8) | 27 (16.8) | 62 (15.4) | 0.675 |
Non-sepsisb | 31 (5.5) | 14 (8.7) | 17 (4.2) | 0.035 |
Pulmonary cause | 434 (76.8) | 112 (69.6) | 322 (79.7) | 0.010 |
Extrapulmonary cause | 117 (20.7) | 41 (25.5) | 76 (18.8) | 0.078 |
Values are presented as mean ± SD, number (%), or median (interquartile range).
SOFA, sequential organ failure assessment; PaO2, arterial partial pressure of oxygen; FiO2, fraction of inspired oxygen; ARDS, acute respiratory distress syndrome; CAP, community-acquired pneumonia; HCAP, healthcare-associated pneumonia; HAP, hospital-acquired pneumonia.